Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.64 USD | -1.87% | +1.87% | +32.30% |
03-15 | North American Morning Briefing : Inflation -2- | DJ |
03-14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
Business Summary
Number of employees: 171
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rebecca Kuhn
FOU | Founder | 63 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Cairn Seale
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-12-31 |
Martha Morrell
CTO | Chief Tech/Sci/R&D Officer | 66 | 97-11-18 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
Stacey Ellul
LAW | General Counsel | - | 22-11-30 |
Irene Thomas
HRO | Human Resources Officer | 55 | 99-12-31 |
Dylan St. John
PRN | Corporate Officer/Principal | 46 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Andrade
BRD | Director/Board Member | 52 | 21-10-31 |
Joseph Lacob
BRD | Director/Board Member | 68 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Uri Geiger
BRD | Director/Board Member | 56 | 23-01-04 |
Renee Ryan
BRD | Director/Board Member | 55 | 20-07-31 |
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rakhi Kumar
BRD | Director/Board Member | 44 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,719,838 | 23,124,862 ( 80.52 %) | 0 | 80.52 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.30% | 392M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |
- Stock Market
- Equities
- NPCE Stock
- Company NeuroPace, Inc.